Author

Ali W. Bseiso

Observed names: A. Bseiso, AW Bseiso, Ali Bseiso

Institutions: University Hospitals of Cleveland, University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center, Case Western Reserve University

Observed institutions: University of Jordan, Marshfield Clinic, The University of Texas MD Anderson Cancer Center, University Hospitals of Cleveland, Marshfield Clinic, University Hospitals Cleveland Medical Center, University Hospitals Seidman Cancer Center, Marshfield Clinic, Case Western Reserve University

OpenAlex ID: A5110241341

Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703.

2023 · Matthew Joseph Wieduwilt, Jun Yin, et al. · Journal of Clinical Oncology · 51

High Prevalence of Factor V Leiden in Healthy Jordanian Arabs

1999 · A. Awidi, M. Shannak, et al. · Thrombosis and Haemostasis · 38

Myelodysplastic syndrome following successful therapy of acute promyelocytic leukemia

1997 · AW Bseiso, H Kantarjian, et al. · Leukemia · 26

S117: Chemotherapy-free Treatment With Inotuzumab Ozogamicin and Blinatumomab for Older Adults With Newly-diagnosed, Ph-negative, Cd22-positive, B-cell Acute Lymphoblastic Leukemia: Alliance A041703

2023 · Matthew Wieduwilt, Jun Yin, et al. · HemaSphere · 13

Inotuzumab Ozogamicin Then Blinatumomab for Older Adults With Newly Diagnosed B-Cell ALL: Alliance Study A041703 Cohort 1 Results

2025 · Matthew J. Wieduwilt, Jun Yin, et al. · Journal of Clinical Oncology · 12

Presentation of Malignant Pleural Mesothelioma with Symptomatic Brain Metastasis: Report of a Case

2004 · Michael Huncharek, Ali Bseiso, et al. · Tumori Journal · 6

Inotuzumab ozogamicin then blinatumomab for older adults with newly diagnosed, ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Extended follow-up of alliance for clinical trials in oncology A041703 cohort 1 reveals durable remission and survival

2025 · Matthew Wieduwilt, Jun Yin, et al. · Blood · 4

The Indolent Lymphomas

2005 · Ali W. Bseiso, Peter McLaughlin · 3

Bendamustine + Rituximab (BR) Chemoimmunotherapy and Maintenance Lenalidomide in Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL): A Wisconsin Oncology Network (WON) Study

2012 · Julie E. Chang, Chong Zhang, et al. · Blood · 2

Efficacy of skin microvasculature C5b-9 and MASP2 deposition in transplant-associated thrombotic microangiopathy

2026 · Michael Daunov, John Sumodi, et al. · Leukemia & lymphoma/Leukemia and lymphoma

Addition of ATG and Reduced-Dose Post-Transplant Cyclophosphamide Results in Faster Count Recovery without Excess GVHD

2026 · Olga Lytvynova, Eric Irons, et al. · Transplantation and Cellular Therapy

A Retrospective Study of C5b-9 and MASP2 Deposition in Skin Microvasculature As a Prognostic and Diagnostic Tool for Transplant-Associated Thrombotic Microangiopathy

2024 · Michael Daunov, John Sumodi, et al. · Blood

CHOP-Rituximab-Interferon Therapy in Follicular Lmphoma (FL): High Remissions with Reasonable Toxicity.

2006 · Ali W. Bseiso, William G. Hocking, et al. · Blood

Works count: 13

Citation count: 155

H-index: 6

I10-index: 5